Alfresa's ethical pharma wholesale business net sales FY 2014-2018
This statistic depicts the net sales of Alfresa Holdings Corporation's ethical pharmaceuticals wholesaling business from fiscal year 2014 to 2017, with a forecast for 2018. In fiscal 2018, the Japanese pharmaceutical company was forecast to reach net sales amounting to approximately 2.3 trillion Japanese yen in the ethical pharma wholesaling business, an increase from around 2.21 trillion yen in fiscal year 2014.